Ladislav Šenolt

11.7k total citations · 1 hit paper
174 papers, 8.4k citations indexed

About

Ladislav Šenolt is a scholar working on Rheumatology, Molecular Biology and Immunology. According to data from OpenAlex, Ladislav Šenolt has authored 174 papers receiving a total of 8.4k indexed citations (citations by other indexed papers that have themselves been cited), including 100 papers in Rheumatology, 65 papers in Molecular Biology and 42 papers in Immunology. Recurrent topics in Ladislav Šenolt's work include Rheumatoid Arthritis Research and Therapies (57 papers), Spondyloarthritis Studies and Treatments (29 papers) and Systemic Sclerosis and Related Diseases (29 papers). Ladislav Šenolt is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (57 papers), Spondyloarthritis Studies and Treatments (29 papers) and Systemic Sclerosis and Related Diseases (29 papers). Ladislav Šenolt collaborates with scholars based in Czechia, Switzerland and Denmark. Ladislav Šenolt's co-authors include Karel Pavelká, Jiří Vencovský, Jörg H. W. Distler, Michal Tomčík, Radim Bečvář, Martin Komarc, Maja Špiritović, Hana Štorkánová, Barbora Heřmánková and Sabína Oreská and has published in prestigious journals such as Nature Communications, PLoS ONE and Scientific Reports.

In The Last Decade

Ladislav Šenolt

168 papers receiving 8.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Plasma Hsp90 levels in patients with systemic sclerosis and relation to lung and skin involvement: a cross-sectional and longitudinal study

2021 4.1k citations Hana Štorkánová, Sabína Oreská et al. Scientific Reports profile →

Peers

Countries citing papers authored by Ladislav Šenolt

Since Specialization

Citations

This map shows the geographic impact of Ladislav Šenolt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ladislav Šenolt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ladislav Šenolt more than expected).

Fields of papers citing papers by Ladislav Šenolt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ladislav Šenolt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ladislav Šenolt. The network helps show where Ladislav Šenolt may publish in the future.

Co-authorship network of co-authors of Ladislav Šenolt

This figure shows the co-authorship network connecting the top 25 collaborators of Ladislav Šenolt. A scholar is included among the top collaborators of Ladislav Šenolt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ladislav Šenolt. Ladislav Šenolt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Machine learning-assisted screening of clinical features for predicting difficult-to-treat rheumatoid arthritis 2025 ·Scientific Reports ·Jiří Baloun, Lucie Andrés Cerezo, (unknown), (unknown), (unknown), H. Mann, Jiří Vencovský, Karel Pavelká, Ladislav Šenolt	0
2	Sexual function and pelvic floor function in men with systemic sclerosis compared to healthy controls: a cross-sectional study 2024 ·The Aging Male ·Barbora Heřmánková, Sabína Oreská, Maja Špiritović, Hana Štorkánová, Martin Komarc, Karel Pavelká, Ladislav Šenolt, Jiří Vencovský, Radim Bečvář, Michal Tomčík	0
3	Dexamethasone nanomedicines with optimized drug release kinetics tailored for treatment of site-specific rheumatic musculoskeletal diseases 2024 ·International Journal of Pharmaceutics ·(unknown), Eva Randárová, (unknown), (unknown), (unknown), Lukáš Kubala, Rafał Konefał, (unknown), Lucie Andrés Cerezo, Ladislav Šenolt, Tomáš Etrych	1
4	The association between radiographic progression, functional impairment, markers of dyslipidaemia and inflammation in patients with hand osteoarthritis: a five-year longitudinal study 2024 ·Clinical and Experimental Rheumatology ·Jiří Baloun, (unknown), Lucie Andrés Cerezo, Olga Růžičková, (unknown), J Gatterová, Michal Tomčík, Jiří Vencovský, Karel Pavelká, Ladislav Šenolt	0
5	Interleukin-37: associations of plasma levels and genetic variants in gout 2023 ·Arthritis Research & Therapy ·Lucie Andrés Cerezo, (unknown), Hana Hulejová, Markéta Pavlı́ková, Jakub Závada, Karel Pavelká, Ladislav Šenolt, Blanka Stibůrková	2
6	S100A4-neutralizing monoclonal antibody 6B12 counteracts the established experimental skin fibrosis induced by bleomycin 2023 ·Lara D. Veeken ·(unknown), Hana Štorkánová, Thuong Trinh‐Minh, (unknown), (unknown), Hana Hulejová, Sabína Oreská, Barbora Heřmánková, Radim Bečvář, Karel Pavelká, Jiří Vencovský, Jörg Klingelhöfer, Rizwan I. Hussain, Jonas Hallén, Ladislav Šenolt, Jörg H. W. Distler, Michal Tomčík	6
7	Effect of an 8-Week Tailored Physiotherapy Program on Sexual Health in Women with Scleroderma and Myositis: A Controlled Pilot Study 2023 ·Rheumatology and Therapy ·Barbora Heřmánková, Maja Špiritović, Sabína Oreská, Hana Štorkánová, H. Mann, Karel Pavelká, Ladislav Šenolt, Jiří Vencovský, Radim Bečvář, Michal Tomčík	1
8	Cardiovascular risk in myositis patients compared with the general population 2023 ·Lara D. Veeken ·Sabína Oreská, Hana Štorkánová, (unknown), Jaroslav Kudlička, Vladimír Tuka, (unknown), (unknown), (unknown), Eva Chytilova, J Kvasnička, Maja Špiritović, Barbora Heřmánková, (unknown), (unknown), Karel Pavelká, Ladislav Šenolt, H. Mann, Jiří Vencovský, Michal Vráblík, Michal Tomčík	9
9	Hsp90 as a Myokine: Its Association with Systemic Inflammation after Exercise Interventions in Patients with Myositis and Healthy Subjects 2022 ·International Journal of Molecular Sciences ·(unknown), Hana Štorkánová, Maja Špiritović, (unknown), Sabína Oreská, (unknown), Barbora Heřmánková, Kristýna Bubová, (unknown), (unknown), (unknown), H. Mann, Martin Komarc, Karel Pavelká, Ladislav Šenolt, Josef Zámečnı́k, Jiří Vencovský, Michal Tomčík	6
10	Sexual function in patients with idiopathic inflammatory myopathies: a cross-sectional study 2021 ·Lara D. Veeken ·Barbora Heřmánková, Maja Špiritović, Sabína Oreská, Hana Štorkánová, Martin Komarc, Martin Klein, H. Mann, Karel Pavelká, Ladislav Šenolt, Jiří Vencovský, Michal Tomčík	8
11	Response to secukinumab on synovitis using Power Doppler ultrasound in psoriatic arthritis: 12-week results from a phase III study, ULTIMATE 2021 ·Lara D. Veeken ·Maria Antonietta D’Agostino, Georg Schett, (unknown), Ladislav Šenolt, (unknown), Rubén Burgos‐Vargas, José A. Maldonado‐Cocco, Esperanza Naredo, Philippe Carron, (unknown), (unknown), Maarten Boers, Corine Gaillez	19
12	AB0410 S100A4 PLASMA LEVELS CORRELATE WITH DISEASE ACTIVITY, SKIN FIBROSIS AND INTERSTITIAL LUNG DISEASE IN SYSTEMIC SCLEROSIS PATIENTS 2021 ·Annals of the Rheumatic Diseases ·Hana Štorkánová, Lucie Andrés Cerezo, Sabína Oreská, Maja Špiritović, Barbora Heřmánková, Martin Komarc, Karel Pavelká, Jiří Vencovský, Jörg H. W. Distler, Ladislav Šenolt, Radim Bečvář, Michal Tomčík	2
13	The effect of a 24-week training focused on activities of daily living, muscle strengthening, and stability in idiopathic inflammatory myopathies: a monocentric controlled study with follow-up 2021 ·Arthritis Research & Therapy ·Maja Špiritović, Barbora Heřmánková, Sabína Oreská, Hana Štorkánová, Olga Růžičková, (unknown), Martin Klein, (unknown), Hana Šmucrová, (unknown), (unknown), Martin Komarc, Václav Bunc, Karel Pavelká, Ladislav Šenolt, H. Mann, Jiří Vencovský, Michal Tomčík	16
14	Interleukin-35 in idiopathic inflammatory myopathies 2020 ·Cytokine ·H. Mann, Olga Kryštůfková, Josef Zámečnı́k, Jaromír Háček, Hana Hulejová, Mária Filková, Jiří Vencovský, Ladislav Šenolt	5
15	Serum visfatin levels in patients with axial spondyloarthritis and their relationship to disease activity and spinal radiographic damage: a cross-sectional study 2019 ·Rheumatology International ·Hana Hulejová, (unknown), Kristýna Bubová, Olga Kryštůfková, Mária Filková, H. Mann, Šárka Forejtová, Michal Tomčík, Jiří Vencovský, Karel Pavelká, Ladislav Šenolt	6
16	Serum calprotectin may reflect inflammatory activity in patients with active rheumatoid arthritis despite normal to low C-reactive protein 2018 ·Clinical Rheumatology ·(unknown), Hana Hulejová, Jakub Závada, Martin Komarc, Lucie Andrés Cerezo, H. Mann, Jiří Vencovský, Karel Pavelká, Ladislav Šenolt	27
17	Characteristics of difficult-to-treat rheumatoid arthritis: results of an international survey 2018 ·Annals of the Rheumatic Diseases ·Nadia M T Roodenrijs, Maria J. H. de Hair, Marlies C. van der Goes, Johannes W. G. Jacobs, Paco M J Welsing, Désirée van der Heijde, Daniel Aletaha, Maxime Dougados, Kimme L Hyrich, Iain B. McInnes, Ulf Müeller-Ladner, Ladislav Šenolt, Zoltán Szekanecz, Jacob M. van Laar, György Nagy	90
18	Relationship between serum calprotectin (S100A8/9) and clinical, laboratory and ultrasound parameters of disease activity in rheumatoid arthritis: A large cohort study 2017 ·PLoS ONE ·(unknown), Hana Hulejová, Jakub Závada, Petra Hánová, Martin Komarc, H. Mann, Martin Klein, (unknown), Marta Olejarová, Šárka Forejtová, Olga Růžičková, Jiří Vencovský, Karel Pavelká, Ladislav Šenolt	28
19	Serum Calprotectin Discriminates Subclinical Disease Activity from Ultrasound-Defined Remission in Patients with Rheumatoid Arthritis in Clinical Remission 2016 ·PLoS ONE ·(unknown), Hana Hulejová, Jakub Závada, Martin Komarc, Petra Hánová, Martin Klein, H. Mann, (unknown), Marta Olejarová, Šárka Forejtová, Olga Růžičková, Jiří Vencovský, Karel Pavelká, Ladislav Šenolt	14
20	Současný pohled na diagnostiku a léčbu ankylozující spondylitidy 2011 ·Interní medicína pro praxi ·Ladislav Šenolt	0

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact